Transaction Details

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. | Represents weighted average sales price. The shares were sold at prices ranging from $142.720 to $143.715. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Administrative Trust"). | Represents weighted average sales price. The shares were sold at prices ranging from $143.720 to $144.700. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $144.720 to $145.710. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $145.720 to $146.070. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $142.420 to $143.400. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $143.410 to $144.290. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $145.840 to $146.700. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $146.705 to $147.660. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Represents weighted average sales price. The shares were sold at prices ranging from $147.700 to $147.870. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Excludes 2,000,000 shares transferred without consideration from the Trust to each of the Administrative Trust and the Survivor Trust. | The shares are held by The A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Trust"). | The shares are held by The Alexander Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Survivor Trust").